The Appearance Anxiety Inventory (AAI) is a 10-item self-report questionnaire designed to assess the severity of appearance-related anxiety and behavioral processes characteristic of body dysmorphic disorder (BDD). Developed by David Veale, Eshkevari, Kanakam, Ellison, Costa, and Werner and published in Behavioural and Cognitive Psychotherapy in 2014, the AAI measures three core domains: threat monitoring (vigilance about perceived appearance flaws), camouflaging (hiding or disguising perceived defects), and avoidance (withdrawing from situations due to appearance concerns). A total score of 21 or higher is indicative of clinically significant body image anxiety consistent with BDD. The scale demonstrates strong internal consistency (Cronbach’s α = 0.86) and good convergent validity with the Yale-Brown Obsessive Compulsive Scale Modified for BDD (r = 0.55) and the PHQ-9 (r = 0.58). Zentake’s digital AAI auto-scores results instantly and integrates with your EMR workflow.
The AAI consists of 10 items, each rated on a 5-point Likert scale from 0 (“not at all”) to 4 (“all the time”). The total score is the sum of all 10 items, ranging from 0 to 40. Higher scores indicate greater severity of appearance-related anxiety and BDD-associated behavioral processes.
Clinical interpretation thresholds:
The AAI also yields three subscale scores that provide clinical insight into specific BDD processes:
Zentake automatically calculates the AAI total score and subscale scores upon form submission, flags scores at or above the clinical cutoff of 21, and stores results for longitudinal comparison across patient visits.
Step 1: Select the assessment. Choose the Appearance Anxiety Inventory from your Zentake template library. The digital form includes all 10 validated items with the standard 5-point response scale.
Step 2: Deliver to the patient. Send the AAI to your patient via Zentake’s secure link, patient portal, tablet, or waiting-room kiosk. The AAI is designed for self-administration and does not require clinical supervision.
Step 3: Patient completes the inventory. The AAI takes approximately two to three minutes to complete. Patients rate how frequently they have experienced each appearance-related thought or behavior over the past week.
Step 4: Review auto-scored results. Zentake automatically sums all 10 items, calculates the three subscale scores, and compares the total against the clinical cutoff of 21. Scores at or above threshold are flagged in your dashboard.
Step 5: Use results to guide treatment. The AAI is designed as a process measure that is sensitive to change during treatment. Administer it regularly throughout cognitive-behavioral therapy to track which BDD processes (threat monitoring, camouflaging, avoidance) are responding to intervention. Zentake’s longitudinal tracking displays score trends for both total and subscale scores.
Scoring: Paper AAI requires manual summing of 10 items and optional subscale calculation. Zentake auto-scores the total and all three subscales instantly.
Completion time: Both paper and digital versions take two to three minutes. Digital eliminates clinician time spent scoring and transcribing.
Delivery: Paper forms require printing and in-office distribution. Zentake delivers the AAI remotely via secure link, enabling between-session monitoring during BDD treatment.
Data storage: Paper forms must be manually filed or scanned. Zentake stores all responses in a HIPAA-compliant cloud database with instant retrieval.
Longitudinal tracking: Tracking AAI scores across therapy sessions on paper requires manual chart review. Zentake automatically displays total and subscale score trends across administrations.
Security: Paper forms risk loss and unauthorized access. Zentake uses encryption at rest and in transit with full audit logging.
Integration: Paper results require manual EMR entry. Zentake integrates directly with Elation and other EMR platforms.
Cost: Paper forms incur ongoing printing and staff time costs. Zentake eliminates all paper-related expenses.
What does the Appearance Anxiety Inventory measure?
The AAI measures the severity of appearance-related anxiety and three specific behavioral processes associated with body dysmorphic disorder: threat monitoring (vigilance about appearance), camouflaging (hiding perceived flaws), and avoidance (withdrawing from situations due to appearance concerns). It was specifically designed to track these processes during BDD treatment. Zentake’s digital version auto-scores all domains.
How do you score the AAI?
Each of the 10 AAI items is rated from 0 (not at all) to 4 (all the time). The total score ranges from 0 to 40. A score of 21 or higher indicates clinically significant appearance anxiety consistent with BDD. Zentake calculates both the total and three subscale scores automatically upon form submission.
How long does the AAI take to complete?
The AAI takes approximately two to three minutes to complete. It contains only 10 items with a simple 5-point response scale, making it practical for repeated administration during treatment. Zentake’s digital format allows completion on any device between sessions.
Is the AAI free to use?
The AAI is freely available for clinical and research use. It was published in the peer-reviewed literature without licensing restrictions. Zentake provides a pre-built digital version of the AAI included in all subscription plans.
What population is the AAI designed for?
The AAI was originally validated in adult populations with BDD and in community samples with appearance concerns. It has also been validated for use with adolescents (ages 12 and older) with BDD. Zentake supports administration across both age groups.
Who should administer the AAI?
The AAI is a self-report measure designed to be completed independently by the patient. It does not require clinical supervision or specialized training. Zentake enables secure remote self-administration, allowing patients to complete the AAI between therapy sessions.
How is the AAI different from other body image measures?
Unlike general body image satisfaction scales, the AAI specifically measures the cognitive and behavioral processes that maintain BDD: threat monitoring, camouflaging, and avoidance. This makes it particularly useful as a treatment process measure that can detect which specific mechanisms are changing during therapy.
How often should the AAI be administered?
During active BDD treatment, the AAI is typically administered before each therapy session to track process changes. For screening purposes, it can be administered at intake and at regular clinical intervals. Zentake’s scheduling features support both session-by-session and periodic administration workflows.
1. Veale, D., Eshkevari, E., Kanakam, N., Ellison, N., Costa, A., & Werner, T. (2014). The Appearance Anxiety Inventory: Validation of a process measure in the treatment of body dysmorphic disorder. Behavioural and Cognitive Psychotherapy, 42(5), 605–616.
2. Krebs, G., Fernandez de la Cruz, L., Rijsdijk, F.V., et al. (2024). Psychometric evaluation of the Appearance Anxiety Inventory in adolescents with body dysmorphic disorder. Child Psychiatry & Human Development.
3. Czajkowska, Z., Białaszek, W., & Ostaszewski, P. (2022). Appearance Anxiety Inventory (AAI): Creation and validation of the Polish language version. BMC Psychiatry, 22, 754.
Last updated: March 2026
The leading patient intake platform. HIPAA compliant forms for healthcare providers and organizations. Find out what you're missing!
